Congress just ended. Now what?
ASCO, ESMO, or ESC just closed. What changed? What do we update? MSL teams, brand teams, and medical directors all need field-ready answers within 48 hours.
Why this happens
Congresses generate data faster than teams can process
Major medical congresses release hundreds of abstracts, late-breakers, and oral presentations in a matter of days. Your competitors’ data is out there. New safety signals emerge. Treatment paradigms shift.
But internal teams don’t have the capacity to process it all. Medical directors attend sessions but can’t summarize everything. MSLs need field-ready materials by Monday morning.
The gap between congress close and internal action is where strategic advantage is won or lost. Without a rapid evidence response, your teams discuss last week’s data while competitors are already in the field.
“ESMO ended Friday. By Monday, our competitor’s MSLs were already discussing new data with KOLs. Our team had nothing to share.”
— Associate Director, Scientific Communications, EMEA, Cardiology
Sound familiar?
Typical situations we hear
01
Late-breaker changes everything
A competitor’s late-breaking abstract at ASCO shows superior PFS. Your brand team needs a competitive response within 48 hours.
02
100+ abstracts, no summary
Your therapeutic area had 140 presentations. Nobody has time to read them all, but missing key data means missed strategic signals.
03
MSLs need Monday materials
Field medical teams have KOL meetings on Monday. They need congress highlights and updated talking points before the weekend ends.
04
Cross-functional alignment lag
Medical, Brand, and Access teams each interpret congress data differently. Internal messaging diverges before launch.
What breaks without intervention
The cost of doing nothing
Field teams present outdated data
Without rapid congress updates, MSLs continue using pre-congress materials — losing credibility with KOLs who attended the sessions.
Competitive intelligence gap
Competitors’ new data goes unanalyzed. Strategic implications are missed. Your brand team reacts weeks later.
Internal misalignment on key data
Medical, Brand, and Access interpret the same congress data differently. Inconsistent messaging reaches external stakeholders.
How MAG solves it
From congress hall to field-ready materials
1
Pre-congress tracking setup
Before the congress, we align on priority abstracts, competitor molecules, and key endpoints to monitor.
2
Real-time abstract monitoring
During the congress, our medical experts review presentations as they’re released — identifying high-impact data and competitive signals.
3
Structured evidence synthesis
We synthesize key findings into standardized formats — clinical summaries, competitive assessments, visual abstracts — within 24–48 hours.
4
Field-ready distribution
Deliverables are formatted for immediate use: MSL talking points, medical director briefings, brand team impact assessments.
5
Post-congress strategic debrief
Within one week, we provide a comprehensive strategic assessment with updated competitive landscape and recommendations.
Services we use to solve this
What you get
Typical deliverables
Congress highlight summary
Competitive intelligence brief
Visual abstracts
MSL talking points
Medical director briefing
Updated slide deck inserts
Strategic impact assessment
Real work. Measurable outcomes.
Related case studies
ESC 2024 cardiology congress real-time debrief: 14 abstracts summarized in 24 hours
✓ Field teams briefed before Monday morning rounds
Read case study →
Visual abstract series for ASCO and ESMO: 18 abstracts transformed into shareable medical infographics
✓ Average engagement rate 3.2x higher than traditional PDF summaries
Read case study →
Frequently asked
Common questions
Which congresses do you cover?
We cover all major medical congresses: ASCO, ESMO, ESC, AHA, EHA, EASD, ACR, EULAR, AASLD, and others on request.
Can you provide real-time updates during the congress?
Yes. For high-priority congresses, we offer real-time monitoring with same-day summaries of late-breaking presentations.
Do you handle competitive intelligence analysis?
Absolutely. Every congress debrief includes a competitive landscape update with strategic implications for your brand.
Still have questions about congress coverage?
Book a 20-minute scoping call. We’ll review your situation and suggest the fastest path forward.
Book a scoping call →
Browse all services
Need rapid
congress coverage?
congress coverage?
Tell us which congress and therapeutic area — we’ll set up tracking before the first abstract drops.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// Query: ASCO 2024 pembrolizumab adjuvant melanoma late-breaker
search("pembrolizumab adjuvant melanoma", {
years: [2024, 2025],
output: "structured_table"
})
// 312 records → 18 relevant
Processing 312 abstracts...
Congress Evidence Alert
KEYNOTE-716 5-year update (ASCO 2024 LBA): adjuvant pembrolizumab DFS benefit sustained (HR 0.62, 95% CI 0.51–0.75). Practice-changing for stage IIB–IIC melanoma...